Gastrointestinal neuromuscular disease
Gene: MYL9
PMID:32621347; 3rd family with non-consanguineous parents and 3 TOPs.Created: 20 Jan 2022, 10:27 p.m. | Last Modified: 20 Jan 2022, 10:27 p.m.
Panel Version: 1.15
Second unrelated family reported, bi-allelic LOF variants, promote to Amber.Created: 24 Nov 2020, 9:55 a.m. | Last Modified: 24 Nov 2020, 9:55 a.m.
Panel Version: 0.30
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Megacystis-microcolon-intestinal hypoperistalsis syndrome, MIM#619365
Publications
Single consanguineous family reported with a homozygous deletion including the last exon of the gene. No functional evidence.
Sources: LiteratureCreated: 3 Jul 2020, 6:03 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Megacystis-microcolon-intestinal hypoperistalsis syndrome
Publications
Publications for gene: MYL9 were set to 29453416; 33031641
Gene: myl9 has been classified as Green List (High Evidence).
Phenotypes for gene: MYL9 were changed from Megacystis-microcolon-intestinal hypoperistalsis syndrome to Megacystis-microcolon-intestinal hypoperistalsis syndrome, MIM#619365
Publications for gene: MYL9 were set to 29453416
Gene: myl9 has been classified as Amber List (Moderate Evidence).
Gene: myl9 has been classified as Red List (Low Evidence).
gene: MYL9 was added gene: MYL9 was added to Gastrointestinal neuromuscular disease. Sources: Literature Mode of inheritance for gene: MYL9 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: MYL9 were set to 29453416 Phenotypes for gene: MYL9 were set to Megacystis-microcolon-intestinal hypoperistalsis syndrome Review for gene: MYL9 was set to RED